Search

everythinglearnresearchcommunity

for

Search:↓

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

PRP injections can effectively and safely treat alopecia areata.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Most women with hair loss using 5% topical Minoxidil are satisfied with the treatment, but hair loss still affects their daily habits and social life.

Wounding may stimulate hair growth, but more research is needed to confirm the safety and effectiveness of related treatments.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

New treatments for hair loss include low-dose pills, updated drugs, supplements, light therapy, plasma injections, and advanced hair transplant techniques.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

PRP therapy works better than minoxidil for treating hair loss.

Topical minoxidil significantly increases hair growth in androgenetic alopecia but only some patients see cosmetically acceptable results.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Using lyopreserved umbilical tissue allograft may improve healing and reduce recurrence of pilonidal cysts.

Combining micro-needling, LED therapy, and growth factors with Finasteride® significantly improves hair growth.

No single treatment is clearly effective for central serous chorioretinopathy.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Chitosan scaffolds with silver nanoparticles effectively treat infected wounds and promote faster healing.